Wolverine Trading’s Cytosorbents Corp CTSO Stock Holding History

Wolverine Trading’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-565	Closed	-$39K	–	4351
2023 Q1	$39K	Sell	565 -495	-47%	-$29.7K	﹤0.01%	3886
2022 Q4	$33K	Sell	1,060 -135	-11%	-$4.01K	﹤0.01%	3662
2022 Q3	$32K	Buy	+1,195	New	+$46.7K	﹤0.01%	4277
2021 Q2	–	Sell	-610	Closed	-$103K	–	6116
2021 Q1	$103K	Buy	+610	New	+$116K	﹤0.01%	5423
2020 Q3	–	Sell	-1,085	Closed	-$212K	–	4602
2020 Q2	$212K	Buy	+1,085	New	+$199K	﹤0.01%	3755
2019 Q1	–	Sell	-530	Closed	-$83K	–	4638
2018 Q4	$83K	Sell	530 -105	-17%	-$20.9K	﹤0.01%	4039
2018 Q3	$164K	Sell	635 -725	-53%	-$182K	﹤0.01%	4346
2018 Q2	$192K	Hold	1,360	–	–	﹤0.01%	4411
2018 Q1	$192K	Buy	+1,360	New	+$206K	﹤0.01%	4411
2017 Q4	–	Sell	-1,020	Closed	-$126K	–	4998
2017 Q3	$126K	Buy	1,020 +380	+59%	+$38.7K	﹤0.01%	3995
2017 Q2	$56K	Buy	+640	New	+$56.1K	﹤0.01%	4033

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.06% 1-Year Est. Return

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Wolverine Trading's CTSO Position: Q2 2020 in Review

Wolverine Trading sold out of Cytosorbents Corp (CTSO) in Q2 2020, closing a stake of 1,287 shares — an estimated $236K sold.

Wolverine Trading first reported a position in CTSO in Q2 2016 and held it in 12 quarters. The position peaked at $222K in Q3 2018. 90 funds tracked by Wall St. Rank hold CTSO as of Q2 2020.

Wolverine Trading reported no remaining Cytosorbents Corp position as of Q2 2020 after selling out during the quarter.
Wolverine Trading sold 1,287 Cytosorbents Corp shares in Q2 2020, an estimated $236K.
Wolverine Trading first reported a position in Cytosorbents Corp in Q2 2016 and held it in 12 quarters.
Wolverine Trading's Cytosorbents Corp position peaked at $222K in Q3 2018.
90 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2020.

Based on Wolverine Trading's 13F filing for Q2 2020, filed 13 Aug 2020.